Your browser doesn't support javascript.
loading
Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts.
Lantero-Rodriguez, Juan; Vrillon, Agathe; Fernández-Lebrero, Aida; Ortiz-Romero, Paula; Snellman, Anniina; Montoliu-Gaya, Laia; Brum, Wagner S; Cognat, Emmanuel; Dumurgier, Julien; Puig-Pijoan, Albert; Navalpotro-Gómez, Irene; García-Escobar, Greta; Karikari, Thomas K; Vanmechelen, Eugeen; Ashton, Nicholas J; Zetterberg, Henrik; Suárez-Calvet, Marc; Paquet, Claire; Blennow, Kaj.
Affiliation
  • Lantero-Rodriguez J; Department of Psychiatry & Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. juan.rodriguez.2@gu.se.
  • Vrillon A; Institut national de la santé et de la recherche médicale U1144 Optimisation Thérapeutique en Neuropsychopharmacologie, Université de Paris, Paris, France.
  • Fernández-Lebrero A; Centre de Neurologie Cognitive, Groupe Hospitalo Universitaire Assistance Publique Hôpitaux de Paris Nord Hôpital Lariboisière Fernand-Widal, Paris, France.
  • Ortiz-Romero P; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Snellman A; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Montoliu-Gaya L; Cognitive Decline and Movement Disorders Unit, Neurology Department, Hospital del Mar, Barcelona, Spain.
  • Brum WS; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Cognat E; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Dumurgier J; Department of Psychiatry & Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Puig-Pijoan A; Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland.
  • Navalpotro-Gómez I; Department of Psychiatry & Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • García-Escobar G; Department of Psychiatry & Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Karikari TK; Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
  • Vanmechelen E; Institut national de la santé et de la recherche médicale U1144 Optimisation Thérapeutique en Neuropsychopharmacologie, Université de Paris, Paris, France.
  • Ashton NJ; Centre de Neurologie Cognitive, Groupe Hospitalo Universitaire Assistance Publique Hôpitaux de Paris Nord Hôpital Lariboisière Fernand-Widal, Paris, France.
  • Zetterberg H; Centre de Neurologie Cognitive, Groupe Hospitalo Universitaire Assistance Publique Hôpitaux de Paris Nord Hôpital Lariboisière Fernand-Widal, Paris, France.
  • Suárez-Calvet M; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Paquet C; Cognitive Decline and Movement Disorders Unit, Neurology Department, Hospital del Mar, Barcelona, Spain.
  • Blennow K; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Alzheimers Res Ther ; 15(1): 48, 2023 03 10.
Article in En | MEDLINE | ID: mdl-36899441

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease / Cognitive Dysfunction / Amyloidosis Type of study: Clinical_trials / Risk_factors_studies Limits: Humans Language: En Journal: Alzheimers Res Ther Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alzheimer Disease / Cognitive Dysfunction / Amyloidosis Type of study: Clinical_trials / Risk_factors_studies Limits: Humans Language: En Journal: Alzheimers Res Ther Year: 2023 Document type: Article Affiliation country: